Accès ouvert · CC BY

Remdesivir, Favipiravir and Dexamethasone Linked to SARS CoV-2 Variants of Interest and Concern: Could Molnupiravir and SARS CoV-2 Mass Vaccination Programs Add Oil to The Fire?

Article scientifique 2021 Sciences de la santé Anglais

Résumé

SARS CoV-2 Variants of interest and concern are considered a real challenge to our medical efforts to stem down COVID-19. We suggest that these variants evolve simultaneously in different countries though detected first in some while postulating that some drugs might share in their evolution and recommending that SARS CoV-2 vaccination, probably the subunit not the gene based or the inactivated ones, should be offered only to the high-risk groups after an informed personalized risk benefit ratio has been weighed.

Citer ce document

Kelleni, M. (2021). Remdesivir, Favipiravir and Dexamethasone Linked to SARS CoV-2 Variants of Interest and Concern: Could Molnupiravir and SARS CoV-2 Mass Vaccination Programs Add Oil to The Fire?. https://doi.org/10.31219/osf.io/swp7q

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 05/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Auteur(s)

Statistiques

Consultations (hors robots) : 10

Téléchargements (hors robots) : 0

Méthode de comptage